Search results
PDF. Abstract. Background Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and while European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP.
We endorse the empiric treatment recommendations for MRSA and P. aeruginosa provided by the 2016 Clinical Practice Guideline from IDSA and ATS for the management of adults with hospital-acquired and ventilator-associated pneumonia .
14 sie 2018 · Knowledge of local bacterial pathogens and their antibiotic susceptibility and resistance profiles is the key for effective pharmacologic selection and treatment of pneumonia. Keywords: Pneumonia, Ventilator-associated, Community-acquired, Pediatric, Antibiotic resistance, Microbial pathogens.
In this guideline update, several key changes to evidence-based practice for pneumonia were made, including abandoning HCAP criteria to determine risk for resistant organisms, increasing the use of respiratory cultures, reducing the use of urinary antigen tests, preference of the PSI to guide hospitalization decisions, and avoiding macrolide ...
3 kwi 2023 · Abstract. Background: Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and while European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP.
4 kwi 2023 · In these international guidelines, ERS, ESICM, ESCMID, and ALAT provide evidence-based clinical practice recommendations for diagnosis, empirical treatment, and antibiotic therapy for sCAP, following the GRADE approach.
1 paź 2019 · This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia.
